Stimcell Energetics (STME) Liabilities and Shareholders Equity (2011 - 2026)
Stimcell Energetics (STME) posted quarterly Liabilities and Shareholders Equity of $34521.0 for Q1 2026, up 101.76% year-over-year from $17110.0 in Q1 2025, and down 34.05% quarter-over-quarter from $52345.0 in Q4 2025.
Stimcell Energetics (STME) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Stimcell Energetics' Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $34521.0 for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 101.76% year-over-year to $34521.0; the TTM figure through Feb 2026 stood at $124475.0 (changed 0.4% YoY), while the FY2025 annual figure was $21222.0, down 53.99% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $34521.0, down from $52345.0 in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $103270.0 in Q2 2023, with the low at $13896.0 in Q1 2023.
- The 5-year median for Liabilities and Shareholders Equity is $34521.0 (2026), against an average of $40093.2.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity surged 489.51% in 2024, then slumped 79.11% in 2025.
- Stimcell Energetics' Liabilities and Shareholders Equity stood at $24022.0 in 2022, then fell by 4.74% to $22883.0 in 2023, then soared by 67.57% to $38346.0 in 2024, then surged by 36.51% to $52345.0 in 2025, then plunged by 34.05% to $34521.0 in 2026.
- Business Quant data shows STME's Liabilities and Shareholders Equity at $34521.0 in Q1 2026, $52345.0 in Q4 2025, and $16387.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | 34,521.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 34,521.00 |
| Nov 30, 2025 | 52,345.00 |
| Aug 31, 2025 | 16,387.00 |
| May 31, 2025 | 21,222.00 |
| Feb 28, 2025 | 17,110.00 |
| Nov 30, 2024 | 38,346.00 |
| Aug 31, 2024 | 22,397.00 |
| May 31, 2024 | 46,122.00 |
| Feb 29, 2024 | 81,918.00 |
| Nov 30, 2023 | 22,883.00 |
| Aug 31, 2023 | 62,326.00 |
| May 31, 2023 | 103,270.00 |
| Feb 28, 2023 | 13,896.00 |
| Nov 30, 2022 | 24,022.00 |
| Aug 31, 2022 | 28,576.00 |
| May 31, 2022 | 41,344.00 |
| Feb 28, 2022 | 54,900.00 |
| Nov 30, 2021 | 72,574.00 |
| Aug 31, 2021 | 101,896.00 |
| May 31, 2021 | 52,242.00 |